498 results on '"Anton, Jordi"'
Search Results
2. Monitoring of Adverse Events and Safety in Autoinflammatory Diseases: Real-Life Data from the Eurofever Registry
3. Enhanced Gas-Phase pollutant removal using Pt nanoparticle-modified exfoliated carbon nitride photocatalysts under UV and visible light
4. Multisystem inflammatory syndrome in children and SARS-CoV-2 variants: a two-year ambispective multicentric cohort study in Catalonia, Spain
5. Recent advances in the built-in electric-field-assisted photocatalytic dry reforming of methane
6. Proposed Response Parameters for Twelve‐Month Drug Trial in Juvenile Systemic Sclerosis: Results of the Hamburg International Consensus Meetings
7. Dual latent tuberculosis screening with tuberculin skin tests and QuantiFERON-TB assays before TNF-α inhibitor initiation in children in Spain
8. Baricitinib in juvenile idiopathic arthritis: an international, phase 3, randomised, double-blind, placebo-controlled, withdrawal, efficacy, and safety trial
9. The impact of treatment with avacopan on health-related quality of life in antineutrophil cytoplasmic antibody-associated vasculitis: a post-hoc analysis of data from the ADVOCATE trial
10. Juvenile idiopathic arthritis in the young adult. Methodology, objectives, and initial data from the JUVENSER registry
11. Artritis idiopática juvenil en el adulto joven. Metodología, objetivos y datos iniciales del registro JUVENSER
12. What drives the decision to optimise biological treatment in children and youngsters with juvenile idiopathic arthritis? A discrete-choice experiment
13. Characterization of the nasopharyngeal microbiome in patients with Kawasaki disease
14. Caracterización del microbioma nasofaríngeo en pacientes con enfermedad de Kawasaki
15. Autoantibodies against interleukin-1 receptor antagonist in multisystem inflammatory syndrome in children: a multicentre, retrospective, cohort study
16. Enrichment of Rare Variants of Hemophagocytic Lymphohistiocytosis Genes in Systemic Juvenile Idiopathic Arthritis.
17. New and Updated Recommendations for the Treatment of Juvenile Idiopathic Arthritis–Associated Uveitis and Idiopathic Chronic Anterior Uveitis
18. Kawasaki disease in children younger than 6 months of age: characteristics of a Spanish cohort
19. Fever of Unknown Origin
20. Ventricular Repolarization Parameters and Coronary Involvement in Kawasaki Disease
21. A molecular approach to the synthesis of platinum-decorated mesoporous graphitic carbon nitride as selective CO2 reduction photocatalyst
22. Ruthenium nanoparticles supported on carbon-based nanoallotropes as co-catalyst to enhance the photocatalytic hydrogen evolution activity of carbon nitride
23. INSAID Variant Classification and Eurofever Criteria Guide Optimal Treatment Strategy in Patients with TRAPS: Data from the Eurofever Registry
24. Monitoring of Adverse Events and Safety in Autoinflammatory Diseases: Real-Life Data from the Eurofever Registry
25. Unravelling the clinical heterogeneity of undefined recurrent fever over time in the European registries on Autoinflammation
26. Differences Sustained Between Diffuse and Limited Forms of Juvenile Systemic Sclerosis in an Expanded International Cohort
27. Synthesis of 0D to 3D hybrid-carbon nanomaterials carrying platinum(0) nanoparticles: Towards the electrocatalytic determination of methylparabens at ultra-trace levels
28. Cyclobutane-based peptides/terpyridine conjugates: Their use in metal catalysis and as functional organogelators
29. Light-driven water oxidation using hybrid photosensitizer-decorated Co3O4 nanoparticles
30. ‘One-pot’ engineering of 0D carbon-based inorganic nanoarchitectonics for boosting multitasking catalytic activity
31. The impact of treatment with avacopan on health-related quality of life in antineutrophil cytoplasmic antibody-associated vasculitis: a post-hoc analysis of data from the ADVOCATE trial
32. Abatacept as Monotherapy and in Combination With Methotrexate in Patients With Juvenile Idiopathic Arthritis: Analysis of 2 Phase III Trials
33. Kawasaki disease is more prevalent in rural areas of Catalonia (Spain)
34. En Cataluña la enfermedad de Kawasaki es más prevalente en las zonas rurales
35. Development and Initial Validation of the Macrophage Activation Syndrome/Primary Hemophagocytic Lymphohistiocytosis Score, a Diagnostic Tool that Differentiates Primary Hemophagocytic Lymphohistiocytosis from Macrophage Activation Syndrome
36. Correction to: Proposal for a definition for response to treatment, inactive disease and damage for JIA associated uveitis based on the validation of a uveitis related JIA outcome measures from the Multinational Interdisciplinary Working Group for Uveitis in Childhood (MIWGUC)
37. Anti-MOG encephalitis mimicking small vessel CNS vasculitis
38. The Castilian Spanish version of the Juvenile Arthritis Multidimensional Assessment Report (JAMAR)
39. Application and performance of disease activity indices proposed for patients with systemic sclerosis in an international cohort of patients with juvenile systemic sclerosis
40. Spanish consensus document on diagnosis, stabilisation and treatment of pediatric multisystem inflammatory syndrome related to SARS-CoV-2 (SIM-PedS)
41. Documento español de consenso sobre diagnóstico, estabilización y tratamiento del síndrome inflamatorio multisistémico pediátrico vinculado a SARS-CoV-2 (SIM-PedS)
42. Inborn errors of OAS-RNase L in SARS-CoV-2-related multisystem inflammatory syndrome in children
43. New and updated recommendations for the treatment of juvenile idiopathic arthritis associated uveitis and idiopathic chronic anterior uveitis
44. Artritis en el niño
45. HLA-DRB1*11 and variants of the MHC class II locus are strong risk factors for systemic juvenile idiopathic arthritis
46. Similarities and differences between the immunopathogenesis of COVID-19-related pediatric multisystem inflammatory syndrome and Kawasaki disease
47. Proposed Response Parameters for Twelve‐MonthDrug Trial in Juvenile Systemic Sclerosis: Results of the Hamburg International Consensus Meetings
48. Proposal for a definition for response to treatment, inactive disease and damage for JIA associated uveitis based on the validation of a uveitis related JIA outcome measures from the Multinational Interdisciplinary Working Group for Uveitis in Childhood (MIWGUC)
49. Defining outcome measures in juvenile idiopathic arthritis associated uveitis by a systematic review analysis: do we need a consensus?
50. Corrigendum to The impact of the Eurofever criteria and the new InFevers MEFV classification in real life: Results from a large international FMF cohort
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.